RT @Brandon_Beaber: A nice article comparing different b-cell depleting therapies (briumvi, ocrevus, rituximab, kesimpta) for MS. https://t…
12 followers
1,963 followers
RT @Brandon_Beaber: A nice article comparing different b-cell depleting therapies (briumvi, ocrevus, rituximab, kesimpta) for MS. https://t…
75 followers
RT @Brandon_Beaber: A nice article comparing different b-cell depleting therapies (briumvi, ocrevus, rituximab, kesimpta) for MS. https://t…
1,060 followers
Anti-CD20 monoclonal antibodies selectively reduce CD20+ B & CD20+ T cells & suppress inflam activity. These #monotherapies prevent relapses, reduce new/active brain MRI lesions & lessen #RMS progression: in this review we compare 4 anti-CD20 a